Target intelligence / Profile preview

Rotavirus virion (RV) (RV)

Target
RV
Molecular classification
Virus, Reoviridae, Double-stranded RNA virus, Non-enveloped virus
01

Overview

The Rotavirus virion is a complex, non-enveloped, triple-layered icosahedral particle that serves as the infectious agent for rotavirus gastroenteritis, a leading cause of severe diarrhea in children (Estes & Greenberg, 2013). Its genome comprises 11 segments of double-stranded RNA (dsRNA) that encode structural proteins (VP1-VP4, VP6, VP7) and non-structural proteins (NSP1-NSP6). The virion specifically infects mature enterocytes in the small intestine, where the viral enterotoxin NSP4 triggers a calcium-dependent signaling pathway leading to secretory diarrhea (Desselberger, 2014). Prevention is primarily managed through live-attenuated oral vaccines, such as RotaTeq and Rotarix, which stimulate the production of neutralizing antibodies against the outer capsid proteins VP4 and VP7 (WHO, 2021). While clinical management focuses on oral rehydration therapy, the virion's replication cycle and its structural components are the focus of ongoing research for small-molecule antiviral development (Crawford et al., 2017).

Other names
RotavirusRVHuman rotavirusInfantile gastroenteritis virus
02

Mechanism of action

Active immunization via live-attenuated virus to elicit neutralizing antibodies (IgA) against outer capsid proteins VP7 and VP4; inhibition of viral replication and interference with enterotoxin-mediated secretion (WHO, 2021; Rossignol, 2014).

03

Biological functions

Viral entryViral replicationEnterotoxin productionHost cell lysis
04

Disease associations

GastroenteritisDiarrheaInfection
05

Safety considerations

Intussusception (CDC, 2023)Vaccine-derived viral shedding (WHO, 2021)Severe dehydration in untreated cases (Desselberger, 2014)
06

Interacting drugs

Rotarix

4 more in the full profile.

07

Biomarkers

Stool rotavirus antigen (VP6) (CDC, 2023)Viral RNA (RT-PCR) (Burnett et al., 2020)Serum anti-rotavirus IgA (WHO, 2021)

Beyond the preview

Go deeper on Rotavirus virion (RV) (RV).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Rotavirus virion (RV) (RV).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call